Henry S Bienen - Net Worth and Insider Trading
Henry S Bienen Net Worth
The estimated net worth of Henry S Bienen is at least $696 dollars as of 2024-09-21. Henry S Bienen is the Director of Traws Pharma Inc and owns about 101 shares of Traws Pharma Inc (TRAW) stock worth over $696. Details can be seen in Henry S Bienen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Henry S Bienen has not made any transactions after 2018-05-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Henry S Bienen
Henry S Bienen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Henry S Bienen owns 3 companies in total, including Traws Pharma Inc (TRAW) , Gleacher & Co Inc (GLCH) , and Ryan Specialty Holdings Inc (RYAN) .
Click here to see the complete history of Henry S Bienen’s form 4 insider trades.
Insider Ownership Summary of Henry S Bienen
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TRAW | Traws Pharma Inc | 2018-05-29 | director |
GLCH | Gleacher & Co Inc | 2012-05-24 | director |
RYAN | Ryan Specialty Holdings Inc | 2021-07-21 | director |
Henry S Bienen Latest Holdings Summary
Henry S Bienen currently owns a total of 1 stock. Henry S Bienen owns 101 shares of Traws Pharma Inc (TRAW) as of May 29, 2018, with a value of $696.
Latest Holdings of Henry S Bienen
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TRAW | Traws Pharma Inc | 2018-05-29 | 101 | 6.90 | 696 |
Holding Weightings of Henry S Bienen
Henry S Bienen Form 4 Trading Tracker
According to the SEC Form 4 filings, Henry S Bienen has made a total of 0 transactions in Traws Pharma Inc (TRAW) over the past 5 years. The most-recent trade in Traws Pharma Inc is the acquisition of 44 shares on May 29, 2018, which cost Henry S Bienen around $3,800.
Insider Trading History of Henry S Bienen
- 1
Henry S Bienen Trading Performance
GuruFocus tracks the stock performance after each of Henry S Bienen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Henry S Bienen is -1.02%. GuruFocus also compares Henry S Bienen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Henry S Bienen within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Henry S Bienen's insider trading performs compared to the benchmark.
Performance of Henry S Bienen
Henry S Bienen Ownership Network
Henry S Bienen Owned Company Details
What does Traws Pharma Inc do?
Who are the key executives at Traws Pharma Inc?
Henry S Bienen is the director of Traws Pharma Inc. Other key executives at Traws Pharma Inc include CHIEF MEDICAL OFFICER Victor M Moyo , VP Corp Dev & Gen Counsel Abraham N. Oler , and Chief Medical Officer Steven M Fruchtman .
Traws Pharma Inc (TRAW) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Traws Pharma Inc (TRAW) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Traws Pharma Inc (TRAW) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Traws Pharma Inc (TRAW)'s detailed insider trading history can be found in Insider Trading Tracker table.
Traws Pharma Inc Insider Transactions
Henry S Bienen Mailing Address
Above is the net worth, insider trading, and ownership report for Henry S Bienen. You might contact Henry S Bienen via mailing address: C/o Northwestern University, 375 E Chicago Ave, Room 11-410, Chicago Il 60611.